Literature DB >> 26122845

Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck Cancer.

Chantal Stoepker1, Najim Ameziane1, Petra van der Lelij1, Irsan E Kooi1, Anneke B Oostra1, Martin A Rooimans1, Saskia E van Mil1, Arjen Brink2, Ralf Dietrich3, Jesper A Balk1, Bauke Ylstra4, Hans Joenje1, Stephan M Feller5, Ruud H Brakenhoff6.   

Abstract

Failure to repair DNA damage or defective sister chromatid cohesion, a process essential for correct chromosome segregation, can be causative of chromosomal instability (CIN), which is a hallmark of many types of cancers. We investigated how frequent this occurs in head and neck squamous cell carcinoma (HNSCC) and whether specific mechanisms or genes could be linked to these phenotypes. The genomic instability syndrome Fanconi anemia is caused by mutations in any of at least 16 genes regulating DNA interstrand crosslink (ICL) repair. Since patients with Fanconi anemia have a high risk to develop HNSCC, we investigated whether and to which extent Fanconi anemia pathway inactivation underlies CIN in HNSCC of non-Fanconi anemia individuals. We observed ICL-induced chromosomal breakage in 9 of 17 (53%) HNSCC cell lines derived from patients without Fanconi anemia. In addition, defective sister chromatid cohesion was observed in five HNSCC cell lines. Inactivation of FANCM was responsible for chromosomal breakage in one cell line, whereas in two other cell lines, somatic mutations in PDS5A or STAG2 resulted in inadequate sister chromatid cohesion. In addition, FANCF methylation was found in one cell line by screening an additional panel of 39 HNSCC cell lines. Our data demonstrate that CIN in terms of ICL-induced chromosomal breakage and defective chromatid cohesion is frequently observed in HNSCC. Inactivation of known Fanconi anemia and chromatid cohesion genes does explain CIN in the minority of cases. These findings point to phenotypes that may be highly relevant in treatment response of HNSCC. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 26122845     DOI: 10.1158/0008-5472.CAN-15-0528

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low-risk, nontraditional patients.

Authors:  Morgan A Gingerich; Joshua D Smith; Nicole L Michmerhuizen; Megan Ludwig; Samantha Devenport; Chloe Matovina; Chad Brenner; Steven B Chinn
Journal:  Head Neck       Date:  2018-02-10       Impact factor: 3.147

Review 2.  Functioning mechanisms of Shugoshin-1 in centromeric cohesion during mitosis.

Authors:  Qian Zhang; Hong Liu
Journal:  Essays Biochem       Date:  2020-09-04       Impact factor: 8.000

3.  Intraoral Mitochondrial-Targeted GS-Nitroxide, JP4-039, Radioprotects Normal Tissue in Tumor-Bearing Radiosensitive Fancd2(-/-) (C57BL/6) Mice.

Authors:  Ashwin Shinde; Hebist Berhane; Byung Han Rhieu; Ronny Kalash; Karen Xu; Julie Goff; Michael W Epperly; Darcy Franicola; Xichen Zhang; Tracy Dixon; Donna Shields; Hong Wang; Peter Wipf; Kalindi Parmar; Eva Guinan; Valerian Kagan; Vladimir Tyurin; Robert L Ferris; Xiaolan Zhang; Song Li; Joel S Greenberger
Journal:  Radiat Res       Date:  2016-01-20       Impact factor: 2.841

4.  Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection.

Authors:  Mu-Yan Cai; Connor E Dunn; Wenxu Chen; Bose S Kochupurakkal; Huy Nguyen; Lisa A Moreau; Geoffrey I Shapiro; Kalindi Parmar; David Kozono; Alan D D'Andrea
Journal:  Cell Rep       Date:  2020-02-18       Impact factor: 9.423

5.  Defective sister chromatid cohesion is synthetically lethal with impaired APC/C function.

Authors:  Job de Lange; Atiq Faramarz; Anneke B Oostra; Renee X de Menezes; Ida H van der Meulen; Martin A Rooimans; Davy A Rockx; Ruud H Brakenhoff; Victor W van Beusechem; Randall W King; Johan P de Winter; Rob M F Wolthuis
Journal:  Nat Commun       Date:  2015-10-01       Impact factor: 14.919

6.  Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.

Authors:  Paul B M Essers; Martijn van der Heijden; David Vossen; Reinout H de Roest; C René Leemans; Ruud H Brakenhoff; Michiel W M van den Brekel; Harry Bartelink; Marcel Verheij; Conchita Vens
Journal:  Int J Cancer       Date:  2020-03-30       Impact factor: 7.396

7.  Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell death.

Authors:  Anne M van Harten; Marijke Buijze; Richard van der Mast; Martin A Rooimans; Sanne R Martens-de Kemp; Costa Bachas; Arjen Brink; Marijke Stigter-van Walsum; Rob M F Wolthuis; Ruud H Brakenhoff
Journal:  Oncogenesis       Date:  2019-06-17       Impact factor: 7.485

8.  Sister chromatid cohesion defects are associated with chromosomal copy number heterogeneity in high hyperdiploid childhood acute lymphoblastic leukemia.

Authors:  Larissa H Moura-Castro; Pablo Peña-Martínez; Anders Castor; Roman Galeev; Jonas Larsson; Marcus Järås; Minjun Yang; Kajsa Paulsson
Journal:  Genes Chromosomes Cancer       Date:  2021-01-16       Impact factor: 5.006

9.  Genomic analysis of head and neck cancer cases from two high incidence regions.

Authors:  Sandra Perdomo; Devasena Anantharaman; Matthieu Foll; Behnoush Abedi-Ardekani; Geoffroy Durand; Luciana Albina Reis Rosa; Reetta Holmila; Florence Le Calvez-Kelm; Eloiza H Tajara; Victor Wünsch-Filho; José Eduardo Levi; Marta Vilensky; Jerry Polesel; Ivana Holcatova; Lorenzo Simonato; Cristina Canova; Pagona Lagiou; James D McKay; Paul Brennan
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240

10.  Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma.

Authors:  Caroline V M Verhagen; David M Vossen; Kerstin Borgmann; Floor Hageman; Reidar Grénman; Manon Verwijs-Janssen; Lisanne Mout; Roel J C Kluin; Marja Nieuwland; Tesa M Severson; Arno Velds; Ron Kerkhoven; Mark J O'Connor; Martijn van der Heijden; Marie-Louise van Velthuysen; Marcel Verheij; Volkert B Wreesmann; Lodewyk F A Wessels; Michiel W M van den Brekel; Conchita Vens
Journal:  Oncotarget       Date:  2018-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.